Get started
Author

M.S. Novikova Novikova

Observed names: M. S. Novikova, M.S. Novikova, Maria S. Novikova
Observed institution: Central State Medical Academy
ORCID: 0000-0003-1320-0565
Observed ORCID: 0000-0003-1320-0565
OpenAlex ID: A5029210469
Risk factors for new-onset diabetes after transplantation in kidney transplant recipients: own data and meta-analysis
2025 · Maria S. Novikova, Larisa O. Minushkina, et al. · Terapevticheskii arkhiv · 3
PDF
Immunosuppressive therapy as a risk factor for new-onset diabetes after transplantation
2020 · S. S. Allazova, M. S. Novikova, et al. · Terapevticheskii arkhiv · 3
PDF
Effectiveness and safety of SGLT-2 inhibitors for renal allograft recipients with post-transplant diabetes mellitus: an open single-center prospective study
2022 · M.S. Novikova Novikova, S.S. Allazova Allazova, et al. · Kliničeskaâ nefrologiâ · 2
Risk factors for development of new-onset diabetes after kidney transplantation
2019 · S.S. Allazova, M.S. Novikova, et al. · Clinical pharmacology and therapy · 2
PDF
Post-transplantation diabetes mellitus in patients with kidney allotransplantation
2018 · M.S. Novikova Novikova, S.S. Allazova Allazova, et al. · Kliničeskaâ nefrologiâ · 2
Sulodexide: meta-analysis of the treatment of diabetic nephropathy and literature review
2023 · M.S. Novikova Novikova, O.M. Koteshkova Koteshkova, et al. · Фарматека · 1
Возможности Терапии Хронической Болезни Почек: Коррекция Инсулинорезистентности (обзор Литературы И Собственные Данные)
2013 · M.S. Novikova Novikova, Е.И. Леванковская, et al. · Nephrology (Saint-Petersburg) · 1
Влияние беременности на прогрессирование компонентов метаболического синдрома
2011 · И. О. Макаров, Shilov Em, et al. · Акушерство, гинекология и репродукция · 1
Diabetes mellitus before and after kidney transplantation: five-year outcomes and organizational priorities in the late post-transplant period
2026 · M. B. Antsiferov, S. S. Allazova, et al. · National Health Care (Russia)
PDF
Efficacy and Safety of Sglt-2 Inhibitors In Renal Allograft Recipients: an Open-Label, Single-Center Prospective Study
2025 · M. S. Novikova, L. O. Minushkina, et al. · Kardiologiia
PDF
Malignancies after kidney transplantation: results of a 34-year population-based study
2025 · Maria S. Novikova, Larisa O. Minushkina, et al. · Nephrology (Saint-Petersburg)
Place of GLP-1 receptor antagonists and SGLT-2 inhibitors in modern therapy of type 2 diabetes mellitus
2022 · M.B. Antsiferov Antsiferov, O.M. Koteshkova Koteshkova, et al. · Фарматека
Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin
2022 · M.S. Novikova Novikova, O.M. Koteshkova Koteshkova, et al. · Фарматека
Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus
2021 · M.B. Antsiferov Antsiferov, O.M. Koteshkova Koteshkova, et al. · Фарматека
Comparison of risk factors for developing post-transplant diabetis mellitus in patients with kidney allograft
2020 · S.S. Allazova Allazova, M.S. Novikova Novikova, et al. · Kliničeskaâ nefrologiâ
Нефропротективное влияние коррекции инсу-линорезистентности у больных с хронической болезнью почек
2012 · Е.И. Леванковская, M.S. Novikova Novikova, et al. · Effective Pharmacotherapy
Chronic renal disease, hyperfiltration, metabolic syndrome and hypogonadism: is there a link?
2009 · Yuliya Tishova, Svetlana Kalinchenko, et al. · 11th European Congress of Endocrinology
Works count: 17
Citation count: 15
H-index: 2
I10-index:
Year
Topic
Type